dazucorilant
dazucorilant: 3 clinical trials tracked.
dazucorilant evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
What is verified about dazucorilant, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (3)
An Open-Label, Single-Dose, Adaptive Design Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Dazucorilant
Primary endpoint: Area under the concentration-time curve from time zero to the last non-zero concentration (AUC0-t) of dazucorilant
An Open-Label, Single-Sequence Crossover, Drug-Drug Interaction Study to Characterize the Impact of the Cytochrome P450 3A Inhibitor Itraconazole on the Pharmacokinetics and Safety of Dazucorilant in Healthy, Adult Subjects
Primary endpoint: Maximum observed plasma concentration (Cmax) of dazucorilant
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients With Amyotrophic Lateral Sclerosis (DAZALS)
Primary endpoint: Change from Baseline to Week 24 in the ALS Functional Rating Scale-Revised (ALSFRS-R) total score.